ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.52
0.00%
US Tech 100
17,707.20
-0.09%
S&P 500
5,227.16
0.11%
US Dollar vs CAD
1.36415
-0.18%
Bitcoin
61,917.98
-1.57%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Century Therapeutics Inc (IPSC)

  7. Century Therapeutics Inc (IPSC) News

IPSC

Century Therapeutics (IPSC)

Century Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IPSC
DateTimeSourceHeadlineSymbolCompany
05/10/20246:00AMGlobeNewswire Inc.Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
05/09/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
05/09/20246:30AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IPSCCentury Therapeutics Inc
05/09/20246:30AMGlobeNewswire Inc.Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
05/07/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/07/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/07/20244:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
05/06/20243:52PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
04/23/20246:00AMGlobeNewswire Inc.Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:IPSCCentury Therapeutics Inc
04/11/20246:00AMGlobeNewswire Inc.Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade TherapeuticsNASDAQ:IPSCCentury Therapeutics Inc
04/08/20243:05PMGlobeNewswire Inc.Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
03/25/20246:00AMGlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:IPSCCentury Therapeutics Inc
03/19/20246:00AMGlobeNewswire Inc.Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceNASDAQ:IPSCCentury Therapeutics Inc
03/14/20246:30AMGlobeNewswire Inc.Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:IPSCCentury Therapeutics Inc
03/08/20245:29PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
03/07/20243:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
03/06/20243:19PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
03/05/20245:03PMGlobeNewswire Inc.Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IPSCCentury Therapeutics Inc
02/21/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/21/202412:04PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IPSCCentury Therapeutics Inc
02/16/20243:18PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/07/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/07/20244:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/06/20243:25PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/05/20242:23PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IPSCCentury Therapeutics Inc
02/01/20246:00AMGlobeNewswire Inc.Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IPSCCentury Therapeutics Inc
01/19/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
12/11/20239:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IPSCCentury Therapeutics Inc
12/09/202311:00AMGlobeNewswire Inc.Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ EditsNASDAQ:IPSCCentury Therapeutics Inc
12/06/20233:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IPSCCentury Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IPSC

Your Recent History

NYSE
GME
GameStop
NYSE
AMC
AMC Entertainment
USOTC
ASKH
Astika (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
PLUG
Plug Power
USOTC
EPAZ
Epazz (PK)
USOTC
VDRM
ViaDerma (PK)
NASDAQ
JAGX
Jaguar Health
USOTC
RXMD
Progressive Care (QB)
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
AFFU
Affluence (PK)
USOTC
VXIT
Virexit Technologies (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
HMBL
HUMBL (PK)
USOTC
BABL
Buildablock (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved